01-12-2006 | LETTER TO THE EDITOR
Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes
Published in: Clinical and Experimental Medicine | Issue 4/2006
Login to get access01-12-2006 | LETTER TO THE EDITOR
Published in: Clinical and Experimental Medicine | Issue 4/2006
Login to get access